We are live on ! Find out more
ANAC

ANACOR PHARMACEUTICALS INC COM
ANAC

Delisted

ANAC was delisted on the 23rd of June, 2016.

Back to rankings

2 hedge funds and large institutions have $5.74M invested in ANACOR PHARMACEUTICALS INC COM in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 195 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more call options, than puts

Call options by funds: $14K | Put options by funds: $6K

99% less funds holding

Funds holding: 199 → 2 (-197)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 195

100% less capital invested

Capital invested by funds: $2.48B → $5.74M (-$2.48B)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-197
Holders Change %
-98.99%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
195
Calls
$14K
Puts
$6K
Net Calls
+$8K
Net Calls Change
-$46.5M

Top Buyers

Rank Fund Capital Flow
1
CIM
CIM Investment Management
Pennsylvania
+$273K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$360M
2
BBA
Baker Bros. Advisors
New York
-$274M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$154M
4
PAI
Palo Alto Investors
California
-$119M
5
BFA
BlackRock Fund Advisors
California
-$95.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
YCMGA
26
York Capital Management Global Advisors
New York
– -$24.8M -464,618 Closed
Bank of New York Mellon
27
Bank of New York Mellon
New York
– -$24.6M -460,299 Closed
Adage Capital Partners
28
Adage Capital Partners
Massachusetts
– -$18.7M -350,000 Closed
Norges Bank
29
Norges Bank
Norway
– -$17.8M -332,886 Closed
PC
30
PointState Capital
New York
– -$17.4M -325,000 Closed
Morgan Stanley
31
Morgan Stanley
New York
– -$17.2M -321,510 Closed
Citadel Advisors
32
Citadel Advisors
Florida
– -$16.8M -313,988 Closed
Geode Capital Management
33
Geode Capital Management
Massachusetts
– -$16.7K -312,998 Closed
JP Morgan Chase
34
JP Morgan Chase
New York
– -$16.4M -307,192 Closed
T. Rowe Price Associates
35
T. Rowe Price Associates
Maryland
– -$16.1M -300,562 Closed
VOYA Investment Management
36
VOYA Investment Management
Georgia
– -$12.6M -235,387 Closed
BIM
37
BlackRock Investment Management
Delaware
– -$11.6M -216,460 Closed
Deutsche Bank
38
Deutsche Bank
Germany
– -$10.9M -203,576 Closed
SCM
39
Suffolk Capital Management
New York
– -$9.9M -185,321 Closed
TCIM
40
TIAA CREF Investment Management
New York
– -$9.55M -178,668 Closed
RSCM
41
Rock Springs Capital Management
Maryland
– -$9.49M -177,500 Closed
Bank of America
42
Bank of America
North Carolina
– -$9.19M -172,011 Closed
TA
43
Teachers Advisors
New York
– -$8.98M -167,953 Closed
ACA
44
Avoro Capital Advisors
New York
– -$8.91M -166,700 Closed
Charles Schwab
45
Charles Schwab
California
– -$8.5M -158,990 Closed
Balyasny Asset Management
46
Balyasny Asset Management
Illinois
– -$8.44M -157,843 Closed
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
– -$8.38M -156,877 Closed
Ameriprise
48
Ameriprise
Minnesota
– -$7.75M -144,907 Closed
VM
49
VHCP Management
New York
– -$7.52M -140,756 Closed
CS
50
Credit Suisse
Switzerland
– -$6.44M -120,563 Closed
1
2
3 4 5

ANAC Hedge Fund Activity: Q2 2016 in Review

2 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q2 2016, worth a combined $5.74M — down 100% from $2.48B a quarter earlier.

Sellers outnumbered buyers: 195 funds closed out of ANAC and 1 opened new positions — a net loss of 194 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was CIM Investment Management, opening a new position worth an estimated $273K. The largest seller was Fidelity Investments, exiting entirely with an estimated $360M sold.

  • 2 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q2 2016, down from 199 in Q1 2016.
  • Funds reported $5.74M of ANACOR PHARMACEUTICALS INC COM stock for Q2 2016, down 100% quarter-over-quarter.
  • 1 fund opened new ANACOR PHARMACEUTICALS INC COM positions in Q2 2016 and 195 closed out, a net change of -194 holders.
  • The largest ANACOR PHARMACEUTICALS INC COM buyer in Q2 2016 was CIM Investment Management, an estimated $273K added.
  • The largest ANACOR PHARMACEUTICALS INC COM seller in Q2 2016 was Fidelity Investments, an estimated $360M sold.

Based on aggregated 13F filings for Q2 2016.